Last reviewed · How we verify

NCT06744101

Comparative Evaluation of Diffusion Weighted MRI And Ultrasonography In The Detection of Breast Lesions

Active, enrolled Last updated 20 December 2024
What this trial tests

trial testing Evaluate the effectiveness of Diffusion Weighted MRI (DWI) in detecting breast lesions. in Breast LN in 108 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
28 February 2024
Primary endpoint
1 July 2024
1 March 2025

Quick facts

Lead sponsorSuperior University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment108
Start date28 February 2024
Primary completion1 July 2024
Estimated completion1 March 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

Adults 18 to 80, female only, with Breast LN. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to conduct a comparative evaluation of Diffusion Weighted MRI (DW-MRI) and Ultrasonography (US) in detecting breast lesions. Breast cancer remains a leading cause of cancer-related deaths among women worldwide, necessitating efficient and accurate diagnostic methods. Ultrasonography, a commonly used imaging modality, provides valuable insights into breast lesions but has limitations in sensitivity and specificity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06744101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing